Back
AngioDynamics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
50
ANGO
AngioDynamics
Last Price:
7.55
Seasonality Move:
3.94%
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.26
Seasonality Move:
-10.19%
Sell
50
AngioDynamics (ANGO)
is a Sell
Is AngioDynamics a Buy, Sell or Hold?
- The current AngioDynamics [ANGO] share price is $7.55. The Score for ANGO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ANGO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.23. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANGO Stock Price Chart
What is AngioDynamics's stock price today?
-
The AngioDynamics share price today is $7.55
The current trend is moderately bullish and ANGO is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ANGO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 53.25 | Buy |
Chaikin Money Flow: | -78276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.35 - 7.63) | Buy |
Bollinger Bands (100): | (5.97 - 7.49) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 41.35 | Sell |
Chaikin Money Flow: | -3362413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.88 - 15.76) | Sell |
Bollinger Bands (100): | (11.5 - 15.9) | Sell |
ANGO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.57 | Sell |
20-day SMA: | 7.47 | Buy |
50-day SMA: | 7.43 | Buy |
200-day SMA: | 6.51 | Buy |
8-day EMA: | 7.56 | Sell |
20-day EMA: | 7.49 | Buy |
50-day EMA: | 7.27 | Buy |
200-day EMA: | 7.06 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.14 | Sell |
20-day SMA: | 14.89 | Sell |
50-day SMA: | 13.76 | Sell |
200-day SMA: | 11.32 | Buy |
8-day EMA: | 13.91 | Sell |
20-day EMA: | 14.32 | Sell |
50-day EMA: | 13.92 | Sell |
200-day EMA: | 11.52 | Buy |
AngioDynamics Earnings Growth & ANGO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $0.11 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
AngioDynamics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |